Santen Pharmaceutical Earnings Estimates, EPS & Revenue | OTC:SNPHY

Comments

Santen Pharmaceutical Co Ltd Earnings Estimates

SNPHYOTCPK

Trade with Public

$11.56

0.201.77%

At close: Apr 17, 5:00 PM EST

Overview NewsEarningsGuidance Short Interest

Santen Pharmaceutical Earnings Estimates, EPS & Revenue | OTC:SNPHY

Santen Pharmaceutical (SNPHY) is scheduled to report Q3 earnings on May 1, 2026. Analysts estimate EPS of N/A and quarterly revenue of $530.21M.

Earnings Date

Nov 6

EPS

$0.340

Quarterly Revenue

$419.72M

Annual Revenue
(as of Sep 30)

$291.48B

Santen Pharmaceutical Earnings History

Analyze the earnings history of Santen Pharmaceutical using advanced sorting and filters.

Loading calendar...

Santen Pharmaceutical (SNPHY) Earnings Per Share

The chart below shows Santen Pharmaceutical's reported EPS compared to analyst estimates over recent quarters.

Santen Pharmaceutical (SNPHY) Revenue

The chart below shows Santen Pharmaceutical's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Santen Pharmaceutical (OTCPK:SNPHY) reporting earnings?

Santen Pharmaceutical (SNPHY) is scheduled to report earnings on May 12, 2026. The last reported earnings were for reported on November 6, 2025 for Q2.

What were the latest earnings per share (EPS) for Santen Pharmaceutical (OTCPK:SNPHY)?

The Actual EPS was $0.34, which beat the estimate of $0.00.

What were Santen Pharmaceutical’s (OTCPK:SNPHY) revenues?

The Actual Revenue was $419.72M, which beat the estimate of $0.00.

Santen Pharmaceutical Earnings Estimates, EPS & Revenue | OTC:SNPHY

Santen Pharmaceutical (SNPHY) is scheduled to report Q3 earnings on May 1, 2026. Analysts estimate EPS of N/A and quarterly revenue of $530.21M.

Earnings Date

Nov 6

EPS

$0.340

Quarterly Revenue

$419.72M

Annual Revenue
(as of Sep 30)

$291.48B

Santen Pharmaceutical Earnings History

Analyze the earnings history of Santen Pharmaceutical using advanced sorting and filters.

												Get Alert
SNPHY	Santen Pharmaceutical	Q4	$0.05	—	—	—	$506.40M	$442.04M	—	—	05/12/2026	Get Alert
SNPHY	Santen Pharmaceutical	Q3	$0.20	—	—	—	$501.44M	$530.21M	—	—	05/01/2026	Get Alert
SNPHY	Santen Pharmaceutical	Q2	$0.24	—	$0.34	—	$493.21M	—	$419.72M	—	11/06/2025	Get Alert
SNPHY	Santen Pharmaceutical	Q1	$0.22	—	$0.12	—	$479.81M	—	$475.52M	—	08/07/2025	Get Alert
SNPHY	Santen Pharmaceutical	Q4	$0.16	—	$0.05	—	$533.27M	—	$506.40M	—	05/13/2025	Get Alert
SNPHY	Santen Pharmaceutical	Q3	$0.25	—	$0.20	—	$521.40M	—	$501.44M	—	02/06/2025	Get Alert
SNPHY	Santen Pharmaceutical	Q2	$0.25	—	$0.24	—	$508.12M	—	$493.21M	—	11/07/2024	Get Alert
SNPHY	Santen Pharmaceutical	Q1	$0.25	—	$0.22	—	$527.72M	—	$479.81M	—	08/06/2024	Get Alert
SNPHY	Santen Pharmaceutical	Q4	$0.24	—	$0.16	—	$599.14M	—	$533.27M	—	05/09/2024	Get Alert
SNPHY	Santen Pharmaceutical	Q3	$0.13	—	$0.25	—	$474.84M	—	$521.40M	—	02/13/2024	Get Alert
SNPHY	Santen Pharmaceutical	Q2	$0.09	—	$0.25	—	$458.96M	—	$508.12M	—	11/07/2023	Get Alert
SNPHY	Santen Pharmaceutical	Q1	$0.15	—	$0.25	—	$505.98M	—	$527.72M	—	08/03/2023	Get Alert
SNPHY	Santen Pharmaceutical	Q4	$0.20	—	$0.24	—	$596.81M	—	$599.14M	—	05/11/2023	Get Alert
SNPHY	Santen Pharmaceutical	Q3	$0.16	—	$0.13	—	$602.68M	—	$474.84M	—	02/07/2023	Get Alert
SNPHY	Santen Pharmaceutical	Q2	$0.22	—	$0.09	—	$580.33M	—	$458.96M	—	11/08/2022	Get Alert
SNPHY	Santen Pharmaceutical	Q1	$0.21	—	$0.15	—	$591.80M	—	$505.98M	—	08/04/2022	Get Alert
SNPHY	Santen Pharmaceutical	Q4	$0.20	—	$0.20	—	$537.92M	—	$596.81M	—	05/10/2022	Get Alert
SNPHY	Santen Pharmaceutical	Q3	$0.20	—	$0.16	—	$608.18M	—	$602.68M	—	02/10/2022	Get Alert
SNPHY	Santen Pharmaceutical	Q2	$0.25	—	$0.22	—	$576.62M	—	$580.33M	—	11/10/2021	Get Alert
SNPHY	Santen Pharmaceutical	Q1	$0.21	—	$0.21	—	$535.34M	—	$591.80M	—	08/06/2021	Get Alert
SNPHY	Santen Pharmaceutical	Q4	$0.20	—	$0.20	—	$543.13M	—	$537.92M	—	05/11/2021	Get Alert

Loading calendar...

Santen Pharmaceutical (SNPHY) Earnings Per Share

The chart below shows Santen Pharmaceutical's reported EPS compared to analyst estimates over recent quarters.

Santen Pharmaceutical (SNPHY) Revenue

The chart below shows Santen Pharmaceutical's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Santen Pharmaceutical (OTCPK:SNPHY) reporting earnings?

Santen Pharmaceutical (SNPHY) is scheduled to report earnings on May 12, 2026. The last reported earnings were for reported on November 6, 2025 for Q2.

What were the latest earnings per share (EPS) for Santen Pharmaceutical (OTCPK:SNPHY)?

The Actual EPS was $0.34, which beat the estimate of $0.00.

What were Santen Pharmaceutical’s (OTCPK:SNPHY) revenues?

The Actual Revenue was $419.72M, which beat the estimate of $0.00.

												Get Alert
SNPHY	Santen Pharmaceutical	Q4	$0.05	—	—	—	$506.40M	$442.04M	—	—	05/12/2026	Get Alert
SNPHY	Santen Pharmaceutical	Q3	$0.20	—	—	—	$501.44M	$530.21M	—	—	05/01/2026	Get Alert
SNPHY	Santen Pharmaceutical	Q2	$0.24	—	$0.34	—	$493.21M	—	$419.72M	—	11/06/2025	Get Alert
SNPHY	Santen Pharmaceutical	Q1	$0.22	—	$0.12	—	$479.81M	—	$475.52M	—	08/07/2025	Get Alert
SNPHY	Santen Pharmaceutical	Q4	$0.16	—	$0.05	—	$533.27M	—	$506.40M	—	05/13/2025	Get Alert
SNPHY	Santen Pharmaceutical	Q3	$0.25	—	$0.20	—	$521.40M	—	$501.44M	—	02/06/2025	Get Alert
SNPHY	Santen Pharmaceutical	Q2	$0.25	—	$0.24	—	$508.12M	—	$493.21M	—	11/07/2024	Get Alert
SNPHY	Santen Pharmaceutical	Q1	$0.25	—	$0.22	—	$527.72M	—	$479.81M	—	08/06/2024	Get Alert
SNPHY	Santen Pharmaceutical	Q4	$0.24	—	$0.16	—	$599.14M	—	$533.27M	—	05/09/2024	Get Alert
SNPHY	Santen Pharmaceutical	Q3	$0.13	—	$0.25	—	$474.84M	—	$521.40M	—	02/13/2024	Get Alert
SNPHY	Santen Pharmaceutical	Q2	$0.09	—	$0.25	—	$458.96M	—	$508.12M	—	11/07/2023	Get Alert
SNPHY	Santen Pharmaceutical	Q1	$0.15	—	$0.25	—	$505.98M	—	$527.72M	—	08/03/2023	Get Alert
SNPHY	Santen Pharmaceutical	Q4	$0.20	—	$0.24	—	$596.81M	—	$599.14M	—	05/11/2023	Get Alert
SNPHY	Santen Pharmaceutical	Q3	$0.16	—	$0.13	—	$602.68M	—	$474.84M	—	02/07/2023	Get Alert
SNPHY	Santen Pharmaceutical	Q2	$0.22	—	$0.09	—	$580.33M	—	$458.96M	—	11/08/2022	Get Alert
SNPHY	Santen Pharmaceutical	Q1	$0.21	—	$0.15	—	$591.80M	—	$505.98M	—	08/04/2022	Get Alert
SNPHY	Santen Pharmaceutical	Q4	$0.20	—	$0.20	—	$537.92M	—	$596.81M	—	05/10/2022	Get Alert
SNPHY	Santen Pharmaceutical	Q3	$0.20	—	$0.16	—	$608.18M	—	$602.68M	—	02/10/2022	Get Alert
SNPHY	Santen Pharmaceutical	Q2	$0.25	—	$0.22	—	$576.62M	—	$580.33M	—	11/10/2021	Get Alert
SNPHY	Santen Pharmaceutical	Q1	$0.21	—	$0.21	—	$535.34M	—	$591.80M	—	08/06/2021	Get Alert
SNPHY	Santen Pharmaceutical	Q4	$0.20	—	$0.20	—	$543.13M	—	$537.92M	—	05/11/2021	Get Alert

Benzinga

Benzinga

Santen Pharmaceutical Co Ltd Earnings Estimates

Santen Pharmaceutical Earnings Estimates, EPS & Revenue | OTC:SNPHY

Santen Pharmaceutical Earnings History

Santen Pharmaceutical (SNPHY) Earnings Per Share

Santen Pharmaceutical (SNPHY) Revenue

FAQ

When is Santen Pharmaceutical (OTCPK:SNPHY) reporting earnings?

What were the latest earnings per share (EPS) for Santen Pharmaceutical (OTCPK:SNPHY)?

What were Santen Pharmaceutical’s (OTCPK:SNPHY) revenues?

Santen Pharmaceutical Earnings Estimates, EPS & Revenue | OTC:SNPHY

Santen Pharmaceutical Earnings History

Santen Pharmaceutical (SNPHY) Earnings Per Share

Santen Pharmaceutical (SNPHY) Revenue

FAQ

When is Santen Pharmaceutical (OTCPK:SNPHY) reporting earnings?

What were the latest earnings per share (EPS) for Santen Pharmaceutical (OTCPK:SNPHY)?

What were Santen Pharmaceutical’s (OTCPK:SNPHY) revenues?